Target RWE at ISPE 2025

Discover our activities and real-world evidence solutions at the ISPE Annual Meeting & Conference

Explore our Research at ISPE

Target RWE is attending the ISPE Annual Conference from August 22-26, 2025 at the Walter E. Washington Convention Center in Washington DC. 

With a strong focus on causal inference, modern epidemiological methods, and data-agnostic solutions, we continue to redefine how observational data is used to inform healthcare decisions and regulatory-grade evidence generation.  Our presence includes a featured symposium and two poster presentations showcasing real-world applications of advanced causal methods—underscoring our leadership in turning complex methodologies into practical, impactful insights. Visit us at Booth #209 to learn more about our work and explore opportunities to collaborate.

Target RWE Research & Presentations at ISPE

Symposium

Integrating Real-World Data with Randomized Controlled Trials: Advancing Evidence Generation 

Sunday, August 24, 2025

1:30 PM - 3:00 PM ET

This workshop will explore practical strategies for integrating Real-World Data (RWD) with Randomized Controlled Trials (RCTs) to strengthen evidence generation for regulatory, clinical, and research applications. With presentations from international experts and case studies spanning oncology and cardiovascular interventions, attendees will learn methods for designing external control arms, ensuring relevance and reliability of data integration, and extending trial results to broader patient populations.

Oral Presentation

Estimating Artificial Censoring Weights for Clone Censor Weighting Studies: Techniques and Lessons Learned

Sunday, August 24, 2025

12:00 PM - 1:30 PM ET

This oral presentation will focus on practical strategies for implementing clone censor weighting (CCW), a method used to estimate counterfactual outcomes under treatment protocols while addressing challenges such as immortal time bias. Emphasis will be placed on estimating artificial censoring weights—crucial for appropriately reweighting adherent patients.

Oral Presentation

Power vs. Precision When Estimating Risk Differences Using Observational Data: A Case Study from TARGET-IBD

Tuesday, August 26, 2025

12:00 PM - 1:30 PM ET

This oral presentation explores the challenges of applying traditional power-based sample size approaches to real-world observational studies, where sample sizes are fixed and confounding is often present. Using data from the Target RWE's IBD cohort, the study compares power and precision estimates for assessing the risk difference in surgery or hospitalization among patients who achieved early versus late disease remission.

Leadership and Expertise at ISPE

As Chief Scientific Officer of Target RWE, Jennifer Christian, PhD, MPH plays a vital leadership role not only within the organization, but also across the broader field of pharmacoepidemiology through her service to the International Society for Pharmacoepidemiology (ISPE). As an active member of ISPE’s Finance Committee, Dr. Christian brings both scientific and strategic acumen to the Society’s mission—ensuring rigorous fiscal oversight, transparency, and long-term sustainability. Her deep expertise in real-world evidence, combined with her operational leadership at Target RWE, positions her as a trusted advisor and influential contributor to ISPE’s financial governance. Her commitment to advancing evidence-based research and organizational integrity makes her an integral voice in shaping the future of pharmacoepidemiology.

2024 Research Presentations

Making the Case for Negative Control Outcome Studies in Real-World Evidence Research

David Pritchard, PhD, Director of Data Management & Statistics at Target RWE, shares a preview of his presentation for the DIA Real-World Evidence (RWE) Conference: "Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting." In this session, Dr. Pritchard explores the use of Negative Control Outcome (NCO) studies as a methodological strategy to enhance treatment group comparability—ultimately improving the validity and reliability of real-world research. Watch the video to learn how incorporating NCO studies can reduce bias, boost accuracy, and elevate the overall quality of your evidence.

Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence

In this video, Nuvan Rathnayaka, Manager of Biostatistics at Target RWE, shares insights into this innovative approach and discusses how structured communication frameworks can improve the accuracy and reproducibility of real-world data analysis. Click the link to watch the video and learn more about the research, titled "Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence."

Schedule a Meeting With our Team

Jennifer Christian, PharmD, PhD, FISPE

Jennifer Christian, PharmD, PhD, FISPE

Chief Scientific Officer

Alan Brookhart, PhD

Alan Brookhart, PhD

Senior Scientific Advisor

David Pritchard, PhD

David Pritchard, PhD

Director of Data Management & Statistics

Rachel Faller, PhD, MPH

Rachel Faller, PhD, MPH

Senior Epidemiologist

Yasmmyn D. Salinas, PhD, MPH

Yasmmyn D. Salinas, PhD, MPH

Clinical Epidemiologist